Recardio
PrivateLast Round
Series A
Nov 11, 2015
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Recardio is a biotechnology company that develops small molecule therapeutics for cardiovascular diseases that promote natural regenerative capacity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recardio Comparables
Compare Recardio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serca Pharmaceuticals | 77% | |
| CellProthera | 77% | |
| Prolifagen | 77% |
Recardio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased by 200%, from 0 to 2.
- Jan 20, 2026
Monthly visitors increased 2024% MoM, from 41 to 871.
Recardio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Recardio's valuation, stock price, and market status.
Is Recardio a public or private company?
Recardio is a private company.
What is the current stock price of Recardio?
Recardio is a private company with no public stock price. No recent secondary market data is available.
How much is Recardio worth (valuation)?
Valuation information for Recardio is not publicly available.
Can I buy Recardio stock?
Recardio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Recardio's last funding round?
Recardio's most recent funding round was Series A on November 11, 2015.
Who are the main investors in Recardio?
Investor information for Recardio is not publicly disclosed.
Will Recardio IPO soon?
No public IPO plans have been announced for Recardio.
How can I track Recardio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Recardio's secondary market activity and sign up for updates.